Across
- 4. This monoclonal antibody may cause the reactivation of Hep B.
- 5. This "-mib" requires a minimum of 72 hours between doses.
- 7. This Tyrosine Kinase inhibitor must be dosed with Capecitabline.
- 8. This monoclonal antibody requires a pregnancy test prior to first treatment.
- 10. This a PI3K-delta inhibitor with a black box warning of severe diarrhea/bowel perforation/heptotoxicity.
- 13. This is a VEGF inhibitor as known as Zaltrap.
- 17. This monoclonal antibody has the side effects of HI perforation, HF, delayed wound healing and possible hyperglycemia.
- 19. This "-mib" is the first oral version of this class with major CYP3A4 interactions.
- 20. This is a "-degib" has a possible side effects including muscle pain/myalgia/rhabdo.
Down
- 1. This tyrosine Kinase inhibitor may need to be adjusted for renal impaired patient
- 2. This mTOR is given by mouth daily.
- 3. The use of certain medications concurrently with pH modifying drugs may decrease this drug's aborptions
- 6. This is a Histon Deacetylase Inhibitor that s given IV during the first week of a three week cycle.
- 8. This mTOR is given once weekly via IV.
- 9. This "-mib" may cause hyperglycemia.
- 11. This a PARP Inhibitor with secondary malignancies.
- 12. This is a "-stat" is given by mouth every other day for weeks 1 and 2 with off week 3.
- 14. This is a Hedgehog Pathway Inhibitor does not cause ALT/AST elevations.
- 15. This monoclonal antibody requires monitoring of vital signs during the 1st hour after fusion then every eight weeks
- 16. This is a CDK 4 and 6 Inhibitor that is given on a 3 week on and 1 week off cycle.
- 18. This is a "-stat" given by mouth each day.
- 21. This Trrosine Kiase Inhibitor may cause pleural effusion as one of its side effects.
